نتایج جستجو برای: multiagent chemotherapy

تعداد نتایج: 120690  

2016
Lindsay Hladnik,1 Kristan Augustin,2 Sean DeFrates,3

© 2016 Harborside Press® Acute lymphoblastic leukemia (ALL) is a rare form of leukemia, with an estimated 6,250 new cases diagnosed in the United States in 2015 and approximately 1,450 deaths (American Cancer Society, 2015). With current available induction therapies, complete remission (CR) rates in adults are approximately 75% to 90% (Faderl et al., 2010; Bassan & Hoelzer, 2011). After induct...

Journal: :Blood 2007
Cristina Rodríguez-Antona Susanna Leskelä Magdalena Zajac Marta Cuadros Javier Alvés Maria Victoria Moneo Carmen Martín Juan Cruz Cigudosa Amancio Carnero Mercedes Robledo Javier Benitez Beatriz Martínez-Delgado

Peripheral T-cell lymphomas (PTCLs) are aggressive tumors in which the current therapy based on multiagent chemotherapy is not successful. Since cytochrome P450 3A subfamily (CYP3A) enzymes are involved in the inactivation of chemotherapy drugs, we hypothesized that CYP3A and P-glycoprotein (MDR1) expression in these lymphomas could result in a poor clinical response. We measured tumoral CYP3A ...

Journal: :Pediatrics 2013
Deepa Kolaseri Krishnadas Teresa Shapiro Kenneth Lucas

Patients with relapsed stage 4 neuroblastoma have an extremely poor long-term prognosis, making the investigation of new agents of interest. We report the outcome of the first patient treated in a phase 1 study for relapsed neuroblastoma, using the chemotherapy agent decitabine to upregulate cancer testis antigen expression, followed by a dendritic cell vaccine targeting the cancer testis antig...

Journal: :F1000Research 2022

Background: Ewing’s sarcoma (ES) of the scapula is a rare entity. It often discovered late at metastatic stage disease because its deep location. This neoplasm common in children and adolescents. We present first reported case localized an adult over 40 years-old. Case presentation: A 48-year-old man presented with left shoulder pa...

2012

Patients with relapsed stage 4 neuroblastoma have an extremely poor long-term prognosis, making the investigation of new agents of interest. We report the outcome of the first patient treated in a phase 1 study for relapsed neuroblastoma, using the chemotherapy agent decitabine to upregulate cancer testis antigen expression, followed by a dendritic cell vaccine targeting the cancer testis antig...

Journal: :Advances in Software Engineering 2011

Journal: :International Journal of Software Engineering and Knowledge Engineering 2001

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید